Management of Diabetes Mellitus with Puerarin, a Natural Isoflavone From Pueraria lobata

Diabetes mellitus (DM) has become one of the most challenging public health problems globally. The increasing prevalence and mortality rates call for more effective therapeutic agents, especially for DM complications. Traditional herbs have a long clinical application history for DM treatment. Puera...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of Chinese medicine (1979) Vol. 46; no. 8; p. 1771
Main Authors Chen, Xiuping, Yu, Jie, Shi, Jingshan
Format Journal Article
LanguageEnglish
Published Singapore 2018
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Diabetes mellitus (DM) has become one of the most challenging public health problems globally. The increasing prevalence and mortality rates call for more effective therapeutic agents, especially for DM complications. Traditional herbs have a long clinical application history for DM treatment. Puerarin is a natural isoflavone from Pueraria lobata (Wild.) Ohwi which has been consumed both as a functional food and herb in Eastern Asia countries. Documented data has shown that puerarin has cardio-protective, neuroprotective, anti-oxidative, anti-inflammatory and many other effects. In this review, we will summarize the beneficial effects and underlying mechanisms of puerarin on DM and complications. Puerarin may directly benefit DM by decreasing blood glucose levels, improving insulin resistance, protecting islets, inhibiting inflammation, decreasing oxidative stress and inhibiting Maillard reaction and advanced glycation end products (AGEs) formation. Furthermore, puerarin may also benefit DM indirectly by retarding and improving a series of DM complications, such as cardiovascular complications, diabetic nephropathy, diabetic retinopathy, diabetic neuropathy, etc. However, comprehensive studies of its effect and mechanisms are needed. In addition, its efficacy is relatively low, which is partially due to its pharmacokinetics profiles. Though puerarin shows low toxicity to experimental animals, its safety on human remains to be clarified. Collectively, we suggest that puerarin might be a potential adjuvant agent for the treatment of DM and DM complications in future.
AbstractList Diabetes mellitus (DM) has become one of the most challenging public health problems globally. The increasing prevalence and mortality rates call for more effective therapeutic agents, especially for DM complications. Traditional herbs have a long clinical application history for DM treatment. Puerarin is a natural isoflavone from Pueraria lobata (Wild.) Ohwi which has been consumed both as a functional food and herb in Eastern Asia countries. Documented data has shown that puerarin has cardio-protective, neuroprotective, anti-oxidative, anti-inflammatory and many other effects. In this review, we will summarize the beneficial effects and underlying mechanisms of puerarin on DM and complications. Puerarin may directly benefit DM by decreasing blood glucose levels, improving insulin resistance, protecting islets, inhibiting inflammation, decreasing oxidative stress and inhibiting Maillard reaction and advanced glycation end products (AGEs) formation. Furthermore, puerarin may also benefit DM indirectly by retarding and improving a series of DM complications, such as cardiovascular complications, diabetic nephropathy, diabetic retinopathy, diabetic neuropathy, etc. However, comprehensive studies of its effect and mechanisms are needed. In addition, its efficacy is relatively low, which is partially due to its pharmacokinetics profiles. Though puerarin shows low toxicity to experimental animals, its safety on human remains to be clarified. Collectively, we suggest that puerarin might be a potential adjuvant agent for the treatment of DM and DM complications in future.
Author Chen, Xiuping
Shi, Jingshan
Yu, Jie
Author_xml – sequence: 1
  givenname: Xiuping
  surname: Chen
  fullname: Chen, Xiuping
  organization: † State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao 999078, P. R. China
– sequence: 2
  givenname: Jie
  surname: Yu
  fullname: Yu, Jie
  organization: † State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao 999078, P. R. China
– sequence: 3
  givenname: Jingshan
  surname: Shi
  fullname: Shi, Jingshan
  organization: Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563003, P. R. China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30525896$$D View this record in MEDLINE/PubMed
BookMark eNo1j11LwzAYRoMo7kN_gDeSH2BnPpo276VMp4NNBRV2N940iVbSdjSp4r9XcLt6bg6H80zIcdu1jpALzmac5-L6hXEQOVcbrhVjGvgRGfMSZFZoJUdkEuMnY1yWujglI8mUUBqKMdmsscV317g20c7T2xqNSy7StQuhTkOk33X6oM-D67Gv2yuK9BHT0GOgy9j5gF9_FXTRd82BQRo6gwnPyInHEN35fqfkbXH3On_IVk_3y_nNKqukgJTlEsFCBRpVZXKB2gjmjNWm8LJkTOVOohKa5RoNoLUVlN5brwEqq6HkYkou_727wTTObnd93WD_sz1cFL8a4VRj
CitedBy_id crossref_primary_10_1016_j_phrs_2022_106152
crossref_primary_10_1007_s43032_020_00325_0
crossref_primary_10_1016_j_jff_2022_105284
crossref_primary_10_3389_fphar_2021_771793
crossref_primary_10_1016_j_jep_2024_118703
crossref_primary_10_3390_ani12162109
crossref_primary_10_1080_13880209_2022_2099430
crossref_primary_10_1142_S0192415X21500816
crossref_primary_10_1016_j_livsci_2023_105192
crossref_primary_10_3390_antiox10071064
crossref_primary_10_3390_molecules27249035
crossref_primary_10_1016_j_nano_2024_102786
crossref_primary_10_3389_fimmu_2023_1185317
crossref_primary_10_1016_j_bioactmat_2022_04_032
crossref_primary_10_1016_j_biopha_2020_110977
crossref_primary_10_1515_chem_2022_0311
crossref_primary_10_1155_2021_3665460
crossref_primary_10_3389_fphar_2022_971561
crossref_primary_10_1155_2020_7126914
crossref_primary_10_3390_molecules28103996
crossref_primary_10_1002_fft2_15
crossref_primary_10_1039_D0FO02356F
crossref_primary_10_3390_ph14060569
crossref_primary_10_1016_j_foodres_2022_111401
crossref_primary_10_1016_j_colsurfb_2020_110887
crossref_primary_10_1002_mnfr_202300123
crossref_primary_10_1016_j_ijbiomac_2022_02_015
crossref_primary_10_1093_humupd_dmaa039
crossref_primary_10_1093_burnst_tkac046
crossref_primary_10_1002_jssc_202300672
crossref_primary_10_1039_D0FO02761H
crossref_primary_10_1016_j_ijbiomac_2022_03_004
crossref_primary_10_3389_fimmu_2023_1024120
crossref_primary_10_3390_molecules29122731
crossref_primary_10_3389_fnut_2023_1192131
crossref_primary_10_1155_2021_9940169
crossref_primary_10_1016_j_joim_2020_11_002
crossref_primary_10_3389_fphar_2021_624404
crossref_primary_10_1002_fft2_105
crossref_primary_10_52586_5058
crossref_primary_10_1016_j_fitote_2025_106453
crossref_primary_10_2174_0118715303287050240223073217
crossref_primary_10_1016_j_phymed_2022_154465
crossref_primary_10_3390_life14111473
crossref_primary_10_3390_cancers15113037
crossref_primary_10_1155_2022_9308598
crossref_primary_10_1002_advs_202403219
crossref_primary_10_1016_j_eujim_2024_102405
crossref_primary_10_3892_mmr_2019_10626
crossref_primary_10_3390_molecules25173970
crossref_primary_10_1007_s11596_024_2830_1
crossref_primary_10_4103_wjtcm_wjtcm_63_20
crossref_primary_10_1002_jbt_22583
crossref_primary_10_3390_molecules27134074
crossref_primary_10_1007_s43032_022_01102_x
crossref_primary_10_1155_2022_2136807
crossref_primary_10_4239_wjd_v14_i11_1603
crossref_primary_10_1016_j_biopha_2021_111325
crossref_primary_10_3389_fped_2021_706327
crossref_primary_10_1080_03602532_2020_1714646
crossref_primary_10_1016_j_carbpol_2022_120329
crossref_primary_10_1016_j_jddst_2023_104377
crossref_primary_10_3892_etm_2019_7534
crossref_primary_10_1016_j_cofs_2022_01_002
crossref_primary_10_1021_acs_jafc_0c04119
crossref_primary_10_1016_j_eujim_2021_101388
crossref_primary_10_1016_j_jep_2024_117746
crossref_primary_10_1016_j_phyplu_2023_100506
crossref_primary_10_1016_j_jff_2022_105057
crossref_primary_10_1016_j_phymed_2023_155329
crossref_primary_10_1016_j_jep_2024_119128
crossref_primary_10_3390_foods11233941
crossref_primary_10_3389_fphar_2024_1501990
crossref_primary_10_1016_j_foodchem_2023_136198
crossref_primary_10_1016_j_clinsp_2024_100413
crossref_primary_10_18632_aging_103976
crossref_primary_10_1002_cbdv_202400005
crossref_primary_10_1186_s12944_023_01969_y
crossref_primary_10_1142_S0192415X19500733
crossref_primary_10_3389_fphar_2023_1153600
crossref_primary_10_1016_j_envres_2023_115912
crossref_primary_10_1142_S0192415X19500496
crossref_primary_10_3389_fpls_2022_900035
ContentType Journal Article
DBID NPM
DOI 10.1142/S0192415X18500891
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1793-6853
ExternalDocumentID 30525896
Genre Journal Article
GroupedDBID ---
.GJ
0R~
123
23M
36B
4.4
53G
5RE
6J9
6NX
6PF
AAWTL
ADSJI
AEGXH
AENEX
AFOSN
AIZAD
ALMA_UNASSIGNED_HOLDINGS
C1A
CAG
COF
CS3
EBS
ECV
EJD
EMOBN
F5P
FAL
FEDTE
FJD
FJW
HVGLF
HZ~
NPM
O9-
P2P
P71
PQQKQ
RWJ
WH7
WQ9
WSL
ZGI
ZXP
ID FETCH-LOGICAL-c329t-43a9d9c98a5cb42a8b20ebd8b6f370054e3a528048ab9addc97ffdf899cd89712
IngestDate Thu Apr 03 07:00:29 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Diabetic Complications
Radix Puerariae
Review
Diabetes Mellitus
Puerarin
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c329t-43a9d9c98a5cb42a8b20ebd8b6f370054e3a528048ab9addc97ffdf899cd89712
PMID 30525896
ParticipantIDs pubmed_primary_30525896
PublicationCentury 2000
PublicationDate 2018-00-00
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – year: 2018
  text: 2018-00-00
PublicationDecade 2010
PublicationPlace Singapore
PublicationPlace_xml – name: Singapore
PublicationTitle The American journal of Chinese medicine (1979)
PublicationTitleAlternate Am J Chin Med
PublicationYear 2018
SSID ssj0013786
Score 2.4915829
SecondaryResourceType review_article
Snippet Diabetes mellitus (DM) has become one of the most challenging public health problems globally. The increasing prevalence and mortality rates call for more...
SourceID pubmed
SourceType Index Database
StartPage 1771
Title Management of Diabetes Mellitus with Puerarin, a Natural Isoflavone From Pueraria lobata
URI https://www.ncbi.nlm.nih.gov/pubmed/30525896
Volume 46
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTxsxELYCSCiXigKF0od86K1sm33aPlYBRJGCKjVIe0O214ZIsImUTQ_lz3f8yi7hocJlFdlOstrv29lvxjszCH0Z5BVXBJwccNR0lEkZR5QTHimZpCpLFXgAJjl5dF6cXmRnZV72enfd7JJGfJN_H80reQ2qMAa4mizZFyC7_FEYgM-ALxwBYTj-F8btuytG8x2FMOrIFNlsFj5x7dfCVsWw1oWbl5NtoY2f86m-4X-moDFPTIaJX8W_mgIhDe9q1nGbfFJ3K02Y1ttqrpbb87bmEyOsE1wY-tyPcrKYhWek7QJmyTNZkuq3bS0MI_XV_Nrz1YciYtoJRShnPuFujwrqyv8G--pDjI5HtGMsY-K6rzy04lli95GNcxjnJUgKUCrs3loAYnZrYU1NJz7q2uI-P7tSWDtMraE1cDFMz1QT6AkbUIQWfhMczub7g3Ppo83w_RWHxAqT8RZ64z0K_MPR4y3qqXobbY48KDuobFmCpxoHluDAEmxYggNLDjHHniO45Qg2HAlrOHYc2UUXJ8fj4Wnk-2lEMk1YE2UpZxWTjPJciizhVCQDJSoqCp0So91VyvOEgk3ngsFzTzKidaXBI5cVZSRO3qH1Gv5zH2GSUK240KBmRZYzxVNmWtkNhK4YzRR5j_bcNbmcuaIpl-FqHTw58wH1W1J9RBsa7lL1CSRfIz5bcP4BOKVU0w
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Management+of+Diabetes+Mellitus+with+Puerarin%2C+a+Natural+Isoflavone+From+Pueraria+lobata&rft.jtitle=The+American+journal+of+Chinese+medicine+%281979%29&rft.au=Chen%2C+Xiuping&rft.au=Yu%2C+Jie&rft.au=Shi%2C+Jingshan&rft.date=2018-01-01&rft.eissn=1793-6853&rft.volume=46&rft.issue=8&rft.spage=1771&rft_id=info:doi/10.1142%2FS0192415X18500891&rft_id=info%3Apmid%2F30525896&rft_id=info%3Apmid%2F30525896&rft.externalDocID=30525896